{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:10:29Z","timestamp":1789017029614,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myopia has become an increasingly serious global issue. Preventing myopia and avoiding the risks of high myopia has become an important concern for children, adolescents and their parents. Dual-mechanism myopia control lenses (DMMCL) is a specialized design spectacle lens based on peripheral defocus theory and retinal contrast theory. Although the benefits of peripheral defocus lenses and retinal contrast-designed lenses (RCDL) in myopia prevention have been confirmed, whether the lenses integrating both two designs can effectively prevent further progression of myopia still requires further research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To report the protocol of a clinical trial designed to evaluate the efficacy and safety of DMMCL vs. RCDL alone for slowing the progression of myopia among school-age children in China. The primary objective of this study is to evaluate whether DMMCL are equivalent to RCDL in controlling myopia progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method and analysis<\/jats:title>\n                    <jats:p>\n                      This is a prospective, single-center, non-randomized, equivalence trial designed to compare the efficacy and safety of DMMCL vs. RCDL for controlling myopia progression in children aged 6\u201312 years over a 12-month period. The primary outcome is change in axial length (AL) from baseline to 12 months. We hypothesize that the two treatments are equivalent within a prespecified margin of \u00b10.15\u2005mm. This study will enroll 120 myopic children, aged 6\u201312 years, with cycloplegic spherical equivalent (SE) ranging from \u22120.50 D to \u22126.00 D in both eyes. Eligible participants will be assigned to the DMMCL group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960) or the RCDL group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960) according to their own preferences, or those of their guardians. Participants will be advised to wear their assigned spectacles full-time throughout the trial. All participants will be advised to engage in at least 2\u2005h outdoors per day and will be scheduled for regular follow-up visits. AL, cycloplegic SE, and binocular visual function will be assessed at baseline and throughout the 12-month study period. Both groups will complete questionnaires on adaptation and visual quality one week and one month after wearing the lenses. Participants from both groups will require a follow up visit every 3 months. The primary endpoint is the 12-month change from baseline in AL. Secondary outcomes include changes in cycloplegic SE and binocular vision. Adaption and vision quality questionnaire results are pre-specified outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome<\/jats:title>\n                    <jats:p>Primary outcomes: Twelve-month changes in AL Secondary outcomes: Twelve-month changes in SE from baseline and binocular visual function parameters. Other pre-specified outcomes Adaption and vision quality questionnaire results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The future findings of this trial are expected to provide valuable reference for optimizing myopia management strategies and may contribute to the evidence base that informs pediatric eye care policy.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration<\/jats:bold>\n                      :\n                      <jats:ext-link>https:\/\/www.chictr.org.cn\/<\/jats:ext-link>\n                      ,\n                      <jats:ext-link>https:\/\/www.chictr.org.cn\/showproj.html?proj=301629<\/jats:ext-link>\n                      , identifier ChiCTR2600116438.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1931165","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:28:58Z","timestamp":1789014538000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Control effect of dual-mechanism myopia control lenses on myopia in children and adolescents: a prospective, 12-month, non-randomized, parallel-controlled, and single-center trial protocol"],"prefix":"10.3389","volume":"13","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Optometry Engineering, Jinling Institute of Technology","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Nanjing Vision Jingling Eye Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-qi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Fuyang Vision Zeming Eye Hospital","place":["Fuyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Nanjing Vision Jingling Eye Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Zhou","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Nanjing Vision Jingling Eye Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Si","family":"Gu","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Nanjing Vision Jingling Eye Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Nanjing Vision Jingling Eye Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"Mi","DOI":"10.1167\/iovs.18-25983","article-title":"Myopia\u2014a 21st century public health issue","volume":"60","author":"Resnikoff","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/bjo-2023-323887","article-title":"Advances in myopia control strategies for children","volume":"109","author":"Zhang","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"101577","DOI":"10.1016\/j.lanwpc.2025.101577","article-title":"Myopia and high myopia trends in Chinese children and adolescents over 25 years: a nationwide study with projections to 2050","volume":"59","author":"Pan","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","article-title":"Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort","volume":"138","author":"Hu","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/life15091415","article-title":"The role of spectacle lenses in the control and management of myopia progression: a narrative review","volume":"15","author":"Vitiello","year":"2025","journal-title":"Life (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial","volume":"104","author":"Lam","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ophtha.2023.01.007","article-title":"The efficacy of defocus incorporated multiple segments lenses in slowing myopia progression: results from diverse clinical circumstances","volume":"130","author":"Liu","year":"2023","journal-title":"Ophthalmology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/bjophthalmol-2020-318367","article-title":"One-year myopia control efficacy of spectacle lenses with aspherical lenslets","volume":"106","author":"Bao","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1186\/s12886-025-04584-w","article-title":"Comparison of the effects of spectacle lenses with highly aspherical lenslets combined with atropine for moderate to high myopia control in children","volume":"25","author":"Tang","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/opo.13517","article-title":"Clinical evaluation of MyoCare in Europe (CEME) for myopia management: one-year results","volume":"45","author":"Alvarez-Peregrina","year":"2025","journal-title":"Ophthalmic Physiol Opt"},{"key":"B11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/aos.15649","article-title":"One-year myopia control efficacy of cylindrical annular refractive element spectacle lenses","volume":"101","author":"Liu","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","article-title":"Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)","volume":"107","author":"Rappon","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2147\/OPTH.S453790","article-title":"Evaluation of lag of accommodation with full-field diffusion optics technologyTM (DOT) contrast management spectacle lenses in emmetropic children","volume":"18","author":"Jabeen","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0312935","DOI":"10.1371\/journal.pone.0312935","article-title":"Efficacy of defocus incorporated multiple segments (DIMS) lenses and low-dose atropine on retarding myopic shift among premyopic preschoolers: protocol for a prospective, multicenter, randomized controlled trial","volume":"19","author":"Yang","year":"2024","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40662-025-00427-3","article-title":"Myopia control efficacy of spectacle lenses with highly aspherical lenslets: results of a 5-year follow-up study","volume":"12","author":"Li","year":"2025","journal-title":"Eye and Vis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.3390\/jcm14217872","article-title":"Next-generation spectacle lenses for myopia control: optical designs, mechanisms, and clinical efficacy","volume":"14","author":"Singh","year":"2025","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/opo.13386","article-title":"Visual impact of diffusion optic technology lenses for myopia control","volume":"44","author":"Wolffsohn","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"key":"B18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/bjo-2025-327629","article-title":"Efficacy of spectacle lenses for myopia control: a meta-analysis of randomised controlled trials","volume":"110","author":"D\u2019Andrea","year":"2026","journal-title":"Br J Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/bjophthalmol-2020-317664","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study","volume":"106","author":"Lam","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"101150","DOI":"10.1016\/j.xops.2026.101150","article-title":"Randomized clinical trial of diffusion optics technology spectacle lenses in a Chinese population (CATHAY): 12-month results","volume":"6","author":"Chen","year":"2026","journal-title":"Ophthalmol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e081477","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 Statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"Br Med J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2589-7500(21)00135-7","article-title":"Association between digital smart device use and myopia: a systematic review and meta-analysis","volume":"3","author":"Foreman","year":"2021","journal-title":"Lancet Digit Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.64.6.6","article-title":"IMI-global trends in myopia management attitudes and strategies in clinical practice-2022 update","volume":"64","author":"Wolffsohn","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/opo.13548","article-title":"Comparative evaluation of different (peripheral defocus based) spectacle designs in preventing myopia progression: a double-blinded randomised clinical trial","volume":"45","author":"Gupta","year":"2025","journal-title":"Ophthalmic Physiol Opt"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e001790","DOI":"10.1136\/bmjophth-2024-001790","article-title":"Control of myopia using diffusion optics spectacle lenses: 4-year results of a multicentre randomised controlled, efficacy and safety study (CYPRESS)","volume":"9","author":"Laughton","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1167\/tvst.13.10.42","article-title":"Diffusion optics technology (DOT): a myopia control spectacle lens based on contrast theory","volume":"13","author":"Neitz","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1167\/iovs.10-5716","article-title":"The effect of two-zone concentric bifocal spectacle lenses on refractive error development and eye growth in young chicks","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.62.5.1","article-title":"IMI 2021 Reports and digest\u2014reflections on the implications for clinical practice","volume":"62","author":"Wolffsohn","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.62.5.6","article-title":"IMI Prevention of myopia and its progression","volume":"62","author":"Jonas","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1931165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:28:59Z","timestamp":1789014539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1931165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":31,"alternative-id":["10.3389\/fmed.2026.1931165"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1931165","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1931165"}}